mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
7e-07 |
mRNA |
leptomycin B |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
8e-07 |
mRNA |
BRD-K88742110 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
9e-07 |
mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-06 |
mRNA |
Vorinostat |
gCSI |
pan-cancer |
AAC |
0.26 |
1e-06 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
1e-06 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-06 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-06 |
mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-06 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-06 |